ESMO Handbook: Rehabilitation Issues During Cancer Treatment and Follow-Up - Editors and Contributors

Editor

Henk van Halteren

Department of Medical Oncology, Admiraal de Ruijter Hospital, Goes, The Netherlands

Contributors

Chapter 1: Safeguarding Exercise Capacity Throughout and After Cancer Treatment

L.M. Buffart - EMGO Institute for Health and Care Research, VU University Medical Center, Department of Epidemiology and Biostatistics, Amsterdam,The Netherlands

A.M. May  Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands

Chapter 2: Cancer Pain

C. I. Ripamonti - Supportive Care in Cancer Unit, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milano, Italy

P. Bossi - Head & Neck Medical Oncology Unit, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milano, Italy

Chapter 3: Cancer-related Fatigue

J. Weis - Department of Psychooncology, Tumor Biology Center, Freiburg, Germany

Chapter 4: Psychological Deterioration

E. Andritsch - University of Graz, Clinical Department of Oncology, University Medical Center of Internal Medicine, Graz, Austria

Chapter 5 - Mucocutaneous Changes

R.V. Lalla - Section of Oral Medicine, University of Connecticut Health Center, Farmington, CT, USA

C. B. Boers-Doets - IMPAQTT, Wormer,The Netherlands and Leiden University Medical Center, Leiden,The Netherlands

Chapter 6: Gastrointestinal Sequelae

C. Donnellan - Department of Gastroenterology, Leeds Teaching Hospitals NHS Trust, Leeds, UK

L. Smith - Macmillan Cancer Support, London, UK

J. Maher - Macmillan Cancer Support, London, UK

Chapter 7: Urological Complications

J. J. Wyndaele - University of Antwerp and Department of Urology, Antwerp University Hospital, Antwerp, Belgium

S. De Wachter - University of Antwerp and Department of Urology, Antwerp University Hospital, Antwerp, Belgium

G. De Win - Department of Urology, Antwerp University Hospital, Antwerp, Belgium

Chapter 8: Sexuality/Reproductive Issues

J. Farthmann - Freiburg University Medical Center, Freiburg, Germany

R. Schwab - Freiburg University Medical Center, Freiburg, Germany

A. Hasenburg - Freiburg University Medical Center, Freiburg, Germany

Chapter 9: Cancer: Social Issues

S. Kreitler - School of Psychological Sciences,TEL-Aviv University; Psycho-Oncology Research Center, Sheba Medical Center, Tel Hashomer, Israel

Chapter 10: Financial Issues

D. J. Bruinvels - Instituut voor Klinische Arbeidsgeneeskunde, Amsterdam,The Netherlands

J. G. Schuurman - A-CaRe, Amsterdam,The Netherlands

Chapter 11: Lifestyle Changes

F. L. Pimentel - Lenitudes, SGPS, Portugal; Health Sciences Department, University of Aveiro, Aveiro, Portugal; Oncology Department, Centro Hospitalar Entre Douro e Vouga, Santa Maria da Feira, Portugal

Chapter 12: Survivorship Care Planning

J. M. Jones - Princess Margaret Cancer Centre, University Health Network, University of Toronto,Toronto, ON, Canada

D. Howell - Princess Margaret Cancer Centre, University Health Network, University of Toronto,Toronto, ON, Canada

Declarations of Interest

Chapter 1: Dr Buffart and Dr Mary have reported no conflicts of interest.

Chapter 2: Dr Ripamonti and Dr Bossi have reported no conflicts of interest.

Chapter 3: Professor Weis has reported no conflicts of interest.

Chapter 4: Dr Andritsch has reported no conflicts of interest.

Chapter 5: Dr Lalla has received research funding from BioAlliance Pharma and has served as a Consultant for Sucampo Ag, iNova Pharmaceuticals, Fera Pharmaceuticals, and Phillips Gilmore Oncology Communications. Dr Boers-Doets has received honoraria from or been a consultant or speaker with Amgen, AstraZeneca, Bayer Pharmaceuticals, Boehringer Ingelheim, Eusa Pharma, GlaxoSmithKline, Merck Serono, Merck Sharp & Dohme, Nordic Pharma, Takeda, Novartis, Pfizer, and Roche.

Chapter 6: Dr Donnellan has received educational grants from Sanofi and Merck Sharp & Dohme. Dr Smith and Professor Maher have reported no conflicts of interest.

Chapter 7: Dr Wyndaele, Dr De Wachter, and Dr De Win have reported no conflicts of interest.

Chapter 8: Dr Farthmann, Dr Schwab, and Professor Hasenburg have reported no conflicts of interest.

Chapter 9: Dr Kreitler has reported no conflicts of interest.

Chapter 10: Dr Bruinvels and Dr Schuurman have reported no conflicts of interest.

Chapter 11: Dr Pimentel has reported no conflicts of interest.

Chapter 12: Dr Jones and Dr Howell have reported no conflicts of interest.

« Previous Page Next Page »

Last update: 10 September 2014